Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates Neutral Rating on KLA Corporation

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
Technology Quantum computing Stock Exchange
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

On March 11, 2024, analyst C J Muse from Cantor Fitzgerald reiterated a Neutral rating on KLA (NASDAQ: KLAC) with a $625 price target. This reaffirmation is in line with the average “Hold” rating and consensus price targets hovering around $623.06. KLA Corporation is a leading company specializing in developing, manufacturing, and marketing control and enhancement solutions for semiconductor production processes. With diversified net sales across various product categories and geographic regions, KLA has a strong presence in the semiconductor equipment and testing market. Recent reports show that multiple analysts, including Cantor Fitzgerald, continue to hold a Neutral stance on KLA.

KLAC Stock Analysis: March 11, 2024 Performance Overview and Investor Recommendations

On March 11, 2024, KLAC stock experienced a slight decline in its performance. The stock opened at $683.45, which was $15.76 lower than its previous close. Throughout the trading day, KLAC shares decreased by $14.62, resulting in a 2.09% drop in its price.

Investors may be monitoring KLAC closely to see if the stock will rebound from this decline or if the downward trend will continue. It is important to consider the overall market conditions and any external factors that may be influencing the stock’s performance.

As always, it is recommended for investors to conduct thorough research and analysis before making any investment decisions. Keeping an eye on price movements, technical indicators, and market trends can help investors make informed choices when it comes to buying or selling KLAC stock.

KLAC Stock Performance Analysis: Revenue Growth but Decline in Net Income and EPS

On March 11, 2024, KLAC stock experienced mixed performances based on the financial data provided by CNN Money. Total revenue for KLAC stood at $10.46 billion for the past year, showing a 13.73% increase compared to the previous year. Additionally, total revenue for the second quarter was reported at $2.48 billion, indicating a 3.56% increase from the previous quarter. The growth in revenue is a positive sign for the company’s financial health and indicates a strong performance in terms of sales.

However, when looking at the net income figures, there is a different story. The net income for KLAC was $3.39 billion for the past year, which remained flat compared to the previous year. On the other hand, the net income for the second quarter was $582.53 million, showing a significant decrease of 21.43% from the previous quarter. This decrease in net income could be a cause for concern for investors, as it indicates a decline in profitability for the company.

Earnings per share (EPS) for KLAC were reported at $24.15 for the past year, showing a 10.2% increase compared to the previous year. However, the EPS for the second quarter was $4.28, indicating a decrease of 20.93% from the previous quarter. This decline in EPS could be attributed to the decrease in net income for the quarter.

Overall, KLAC stock performances on March 11, 2024, showed a mixed picture. While the company experienced growth in total revenue and EPS compared to the previous year, there was a significant decrease in net income and EPS for the second quarter. Investors should closely monitor these financial indicators to assess the company’s future performance and make informed investment decisions.

Tags: KLAC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Tech-Innovations

Analyst Reaffirms Overweight Rating for Marvell Technology with Increased Price Target

Finance_Fiscal (2)

Analyst Remains Bullish on Duckhorn Portfolio NYSENAPA Despite Lowered Price Target

AI travel

Title Surge in Investor Interest and Unusual Options Activity for Carnival NYSECCL

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com